BNC2
Zinc finger protein basonuclin-2
Also known as: BNC2_HUMAN, BSN2, FLJ20043
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6ZN30
- Gene
- BNC2
- Ensembl
- ENSG00000173068
- Chromosome
- 9
- Canonical length
- 1099 aa
- Protein class
- Disease related genes, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoli fibrillar center,Nuclear bodies
OverviewNCBI Gene
This gene encodes a conserved zinc finger protein. The encoded protein functions in skin color saturation. Mutations in this gene are associated with facial pigmented spots. This gene is also associated with susceptibility to adolescent idiopathic scoliosis. [provided by RefSeq, Jul 2016]
Canonical amino-acid sequenceUniProt
1099 residues, UniProt reviewed canonical sequence.
>Q6ZN30|BNC2
1 MAHLGPTPPP HSLNYKSEDR LSEQDWPAYF KVPCCGVDTS QIESEEAEVD VRERETQRDR
61 EPKRARDLTL RDSCTDNSMQ FGTRTTTAEP GFMGTWQNAD TNLLFRMSQQ AIRCTLVNCT
121 CECFQPGKIN LRTCDQCKHG WVAHALDKLS TQHLYHPTQV EIVQSNVVFD ISSLMLYGTQ
181 AVPVRLKILL DRLFSVLKQE EVLHILHGLG WTLRDYVRGY ILQDAAGKVL DRWAIMSREE
241 EIITLQQFLR FGETKSIVEL MAIQEKEGQA VAVPSSKTDS DIRTFIESNN RTRSPSLLAH
301 LENSNPSSIH HFENIPNSLA FLLPFQYINP VSAPLLGLPP NGLLLEQPGL RLREPSLSTQ
361 NEYNESSESE VSPTPYKNDQ TPNRNALTSI TNVEPKTEPA CVSPIQNSAP VSDLTKTEHP
421 KSSFRIHRMR RMGSASRKGR VFCNACGKTF YDKGTLKIHY NAVHLKIKHR CTIEGCNMVF
481 SSLRSRNRHS ANPNPRLHMP MLRNNRDKDL IRATSGAATP VIASTKSNLA LTSPGRPPMG
541 FTTPPLDPVL QNPLPSQLVF SGLKTVQPVP PFYRSLLTPG EMVSPPTSLP TSPIIPTSGT
601 IEQHPPPPSE PVVPAVMMAT HEPSADLAPK KKPRKSSMPV KIEKEIIDTA DEFDDEDDDP
661 NDGGAVVNDM SHDNHCHSQE EMSPGMSVKD FSKHNRTRCI SRTEIRRADS MTSEDQEPER
721 DYENESESSE PKLGEESMEG DEHIHSEVSE KVLMNSERPD ENHSEPSHQD VIKVKEEFTD
781 PTYDMFYMSQ YGLYNGGGAS MAALHESFTS SLNYGSPQKF SPEGDLCSSP DPKICYVCKK
841 SFKSSYSVKL HYRNVHLKEM HVCTVAGCNA AFPSRRSRDR HSANINLHRK LLTKELDDMG
901 LDSSQPSLSK DLRDEFLVKI YGAQHPMGLD VREDASSPAG TEDSHLNGYG RGMAEDYMVL
961 DLSTTSSLQS SSSIHSSRES DAGSDEGILL DDIDGASDSG ESAHKAEAPA LPGSLGAEVS
1021 GSLMFSSLSG SNGGIMCNIC HKMYSNKGTL RVHYKTVHLR EMHKCKVPGC NMMFSSVRSR
1081 NRHSQNPNLH KNIPFTSVDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against BNC2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.59
- Highest tissue expression
- 33 nTPM
Expression across tissuesHPA
Tissue
- smooth muscle: 33 nTPM
- endometrium: 29 nTPM
- ovary: 28 nTPM
- fallopian tube: 18 nTPM
- cervix: 13 nTPM
- colon: 9.3 nTPM
Single-cell type
- mesothelial cells: 1,826 nCPM
- proximal tubule cells: 1,191 nCPM
- epicardial cells: 1,071 nCPM
- leydig cells: 1,049 nCPM
- fibro-adipogenic progenitors: 1,048 nCPM
- ovarian stromal cells: 1,039 nCPM
Immune cell
- gdT-cell: 2.5 nTPM
- total PBMC: 1.5 nTPM
- NK-cell: 0.5 nTPM
- naive CD8 T-cell: 0.3 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
Brain region
- choroid plexus: 22 nTPM
- midbrain: 17 nTPM
- white matter: 16 nTPM
- medulla oblongata: 16 nTPM
- pons: 15 nTPM
- thalamus: 15 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about BNC2.
Disease | AllUniProt
Conditions BNC2 is implicated in, by any mechanism.
- Lower urinary tract obstruction, congenital (LUTO) MIM:618612
Disease | GeneticClinVar
2 pathogenic / likely-pathogenic of 342 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Lower Urinary Tract Obstruction
- Lower urinary tract obstruction, congenital
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.34
- gnomAD pLI
- 0.93
- gnomAD missense Z
- 0.36
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- endochondral bone growth
- mesenchyme development
- regulation of DNA-templated transcription
- roof of mouth development
- tongue development
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads BNC2 as an antibody target. Whether an autoantibody or antibody against BNC2 could matter depends on whether native BNC2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
BNC2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label BNC2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...